Skip to main content
. 2021 Jul 26;12(9):2267–2288. doi: 10.1007/s13300-021-01116-9

Fig. 1.

Fig. 1

Range of mean changes from baseline in HbA1c in clinical studies reported in the summary of product characteristics for GLP-1 RAs [15, 17, 19, 21, 23, 25, 27, 52]. BID twice daily, GLP-1 RA glucagon-like peptide 1 receptor agonist, HbA1c glycated haemoglobin, OD once daily, OW once weekly